Drugs / prourokinase
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07550296 | May 2026 → Dec 2027 expected | ischemic stroke | General Hospital of Shenyang Military Region | Recruiting | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT06841965 | Mar 2025 → Jun 2027 expected | ischemic stroke | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06841978 | Mar 2025 → Jun 2027 expected | ischemic stroke | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06749834 | Jan 2025 → Dec 2026 expected | ischemic stroke | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06115070 | Mar 2025 → Dec 2027 expected | ischemic stroke, thrombotic disease | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT02131220 | Nov 2015 → Aug 2017 | myocardial infarction | Fudan University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01642667 Comparator | Nov 2008 → Nov 2009 | ST-elevation myocardial infarction | Suzhou Landing Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | prourokinase | “intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes).” NCT06841965 ↗6“intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes)” NCT06749834 ↗ “intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes)” NCT06115070 ↗ “intravenous prourokinase (rhPro-UK)” NCT06841978 ↗ |
| Known as | rhPro-UK | “intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes).” NCT06841965 ↗3“intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes)” NCT06749834 ↗ “intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes)” NCT06115070 ↗ “intravenous prourokinase (rhPro-UK)” NCT06841978 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant HUman Prourokinase” NCT02131220 ↗ |
| Route | Other | “20mg intracoronary bolus infusion using selective catheter during PCI” NCT02131220 ↗ |